Based on the clinical disease activity index (CDAI), it was determined that 53.8% of RA patients went into remission as their CD4+ CD25+ CD127low Tregs and HLA-DR+ activated Tregs increased, resulting in a decrease in clinical symptoms of inflammation [127]. This evidence concerns the gene CD4 and rheumatoid arthritis.